- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | DataMEDS AI, Inc.: DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets | 262 | ACCESS Newswire | Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS... ► Artikel lesen | |
| Di | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Wellgistics Health, Inc. Officially Changes Corporate Name To DataMEDS AI, Inc. | 228 | PR Newswire | Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data
TAMPA, Fla.... ► Artikel lesen | |
| Mo | Wellgistics Health, Inc.: Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders | 553 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx artificial intelligence prescription... ► Artikel lesen | |
| 15.07. | Wellgistics Health appoints Brett Thompson as consulting CTO | 2 | Seeking Alpha | ||
| 15.07. | Wellgistics Health ernennt Brett Thompson zum beratenden Chief Technology Officer | 1 | Investing.com Deutsch | ||
| 15.07. | Wellgistics Health, Inc.: Wellgistics Health Appoints Brett Thompson as Chief Technology Officer | 355 | ACCESS Newswire | Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 / Wellgistics Health, Inc. (the "Company" or "Wellgistics")... ► Artikel lesen | |
| 30.06. | Wellgistics-Führungskräfte üben Warrants für 200.000 Aktien aus | 1 | Investing.com Deutsch | ||
| DATAMEDS AI Aktie jetzt für 0€ handeln | |||||
| 30.06. | Wellgistics executives exercise warrants for 200,000 shares | 2 | Investing.com | ||
| 30.06. | Wellgistics Health, Inc.: Wellgistics Health Executive Chairman and President Exercise Warrants | 350 | ACCESS Newswire | Executives exercise previously issued warrants to acquire 200,000 common sharesShares issued in connection with exercise added to existing lock-up agreements TAMPA, FL / ACCESS Newswire / June 30, 2026... ► Artikel lesen | |
| 26.06. | DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc. | 390 | ACCESS Newswire | Name reflects vertically-aligned healthcare ecosystem business model integrating data captured via telemedicine, online pharmacy, lab tests and wearables to perfect patients' digital health twins in... ► Artikel lesen | |
| 12.06. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.06. | Wellgistics Health, Inc.: Wellgistics Health Provides Mid-Year 2026 Corporate Outlook | 415 | ACCESS Newswire | Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain, Medical Drones and Health Lives Here progressRecent capital raise provides capital into late... ► Artikel lesen | |
| 29.05. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.05. | Wellgistics: Aktionäre vereinbaren 90-tägige Sperrfrist für Aktien | 2 | Investing.com Deutsch | ||
| 28.05. | Wellgistics shareholders agree to 90-day share lock-up | 5 | Investing.com | ||
| 28.05. | Wellgistics Health, Inc.: Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock | 434 | ACCESS Newswire | Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement TAMPA, FL / ACCESS Newswire / May 28, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader,... ► Artikel lesen | |
| 28.05. | Wellgistics Health, Inc.: Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M | 743 | ACCESS Newswire | New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital for working capital and general corporate purposes... ► Artikel lesen | |
| 26.05. | Wellgistics Health, Inc.: Wellgistics Health Completes Reverse Split | 501 | ACCESS Newswire | 1-for-50 reverse split of common shares outstanding now complete2,513,425 common shares now outstandingA new CUSIP was issued in connection with reverse split TAMPA, FL / ACCESS Newswire / May 26, 2026... ► Artikel lesen | |
| 21.05. | Wellgistics Health, Inc.: Wellgistics Health Releases Letter to Our Shareholders | 584 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / May 21, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization... ► Artikel lesen |
1 2 3 4 5 Weiter >>
91 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CANOPY GROWTH | 0,814 | +0,92 % | Canopy Growth Corporation (CGC) Dips More Than Broader Market: What You Should Know | ||
| EYEPOINT | 11,300 | +1,80 % | EyePoint, Inc. - 8-K, Current Report | ||
| FILANA THERAPEUTICS | 0,868 | +2,24 % | Filana Therapeutics, Inc.: Filana Therapeutics Reports Q1 2026 Financial Results and Business Update | AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for... ► Artikel lesen | |
| COMPASS PATHWAYS | 10,400 | -0,95 % | Compass Pathfinder Limited: Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy | Post-hoc analysis of support methods used in an open-label Phase 2 COMP360 study showed monitoring and support provided during treatment administration sessions were minimal, non-directive and... ► Artikel lesen | |
| CORBUS PHARMACEUTICALS | 7,720 | 0,00 % | Corbus Pharmaceuticals Holdings, Inc.: Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer | NORWOOD, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical-stage company focused on developing promising new therapies... ► Artikel lesen | |
| DARE BIOSCIENCE | 1,220 | 0,00 % | Daré Bioscience, Inc.: Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies | Each year, an estimated six million women in the United States acquire a high-risk HPV infection - and there are no FDA-approved treatments DARE-HPV development is backed by a $10 million U.S. government... ► Artikel lesen | |
| CITIUS PHARMACEUTICALS | 0,554 | -1,55 % | Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update | $5.6 Million in net revenue for the first half of fiscal 2026 from ongoing launch of LYMPHIR®
Citius Pharma raised $5 million in a registered direct offering; Citius... ► Artikel lesen | |
| ELEDON PHARMACEUTICALS | 3,320 | +1,84 % | Eledon Pharmaceuticals: Rodman & Renshaw startet Coverage mit "Buy"-Rating und 200 % Kurspotenzial | ||
| CENTESSA PHARMACEUTICALS | 34,600 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.06.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 26.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.06.2026ISIN NameCA04058Q1054 ARIZONA... ► Artikel lesen | |
| EXICURE | 1,570 | +3,29 % | Exicure, Inc.: Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement | WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (the "Company") today announced that it received a notification letter from the Listing Qualifications Department of... ► Artikel lesen | |
| COSMOS HEALTH | 0,197 | +5,36 % | Cosmos Health Inc.: Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units | Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually Products are distributed... ► Artikel lesen | |
| CHINA SXT PHARMACEUTICALS | 1,970 | -2,48 % | Morning Market Movers: InMed Pharmaceuticals, INLIF Limited, China SXT Pharmaceuticals, Advanced Biomed See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 7,060 | -0,77 % | Apotex Inc.: Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals | TORONTO, July 1, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex") (TSX: APTX), the largest Canadian-based pharmaceutical company, today announced the closing... ► Artikel lesen | |
| CHAMPIONS ONCOLOGY | 5,200 | 0,00 % | Champions Oncology, Inc.: Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026 | HACKENSACK, NJ / ACCESS Newswire / July 20, 2026 / Champions Oncology, Inc. (NASDAQ:CSBR), a global leader in clinically relevant oncology research models and translational solutions, will report its... ► Artikel lesen | |
| CDT EQUITY | 3,360 | -5,35 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenAU000000AQI2 Sinclair Gold Ltd. 17.07.2026 AU0000478992 Sinclair Gold Ltd. 20.07.2026 Tausch 1:1GB00B0FYMT95 Helical... ► Artikel lesen |
DATAMEDS AI INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von -0,080 (-2,23 %) liegt der Kurs bei 3,500 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DATAMEDS AI INC finden Sie auf Wallstreet Online.